Xip Diagnostics is developing technology, marketing, and distribution partnerships with companies seeking to expand their existing segments, transition legacy products, or develop and grow new markets.
Our flexible model includes strategic alliances and licensing opportunities with small and large companies seeking an easily adaptable technology in which to integrate their assay chemistries. Our technology platform is well suited for pharmacokinetic studies by pharma and biotech companies conducting drug development. Single-use and readerless, the technology is amenable to many field applications involving public health, the military and the environment.
Xip Diagnostics has a strategic partnership with a global diagnostics company to develop animal health tests for worldwide commercialization.